MedPath

A research study to see whether the medicine leuprolide as an injection helps to increase chances of pregnancy in patients undergoing artificial reproductive techniques after the process of embryo transfer

Not Applicable
Conditions
Health Condition 1: null- Infertility
Registration Number
CTRI/2018/07/014958
Lead Sponsor
Bangalore Baptist Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Infertile couples undergoing IVF/ICSI with their own gametes

2. Age above 20 years

3. Willing to provide valid written informed consent

4. Antagonist protocol

5. rhCG ovulation trigger

6. Fresh embryo transfer with at least one embryo available for transfer, with not more than 3 embryos transferred at a time, with their consent

Exclusion Criteria

1. Age greater than 40 years

2. Women on GnRH agonist therapy for controlled ovarian hyperstimulation

3. Prior history of recurrent implantation failure

4. Patients at a high risk of ovarian hyperstimulation syndrome (OHSS)

5. Patients with hydrosalpinx / other uterine anatomical abnormalities (bicornuate uterus, septate uterus etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate at 8 weeks of gestationTimepoint: 8 weeks of gestation
Secondary Outcome Measures
NameTimeMethod
Continuation of pregnancy beyond 24 weeks of gestationTimepoint: 24 weeks of gestation
© Copyright 2025. All Rights Reserved by MedPath